Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial membranes—comprising the inner mitochondrial membrane (IMM) and the outer mitochondrial membrane (OMM)—form the structural foundation of mitochondria, the cell’s primary site for ATP (energy) production. The IMM houses the electron transport chain and ATP synthase, driving oxidative phosphorylation and maintaining a strong membrane potential. The OMM is more permeable, hosting enzymes and proteins involved in signaling, metabolite exchange, and apoptosis regulation. Dysfunction in these membranes—by genetic mutation, chemical damage, or altered lipids—can cause or contribute to a wide range of diseases. Although singular proteins in these membranes are valid drug targets, the "mitochondrial membrane" as such is not considered a therapeutically targetable molecule but a compartment containing many distinct targets.
Disruption of oxidative phosphorylation by inhibiting electron transport chain complexes; Altering mitochondrial permeability (induction or blockade); Modulation of apoptosis by affecting mitochondrial outer membrane permeabilization (MOMP)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial membrane (Inner and Outer).